| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,418 |
5,104 |
$867K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,802 |
3,548 |
$808K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,575 |
1,485 |
$353K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
229 |
220 |
$150K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
708 |
681 |
$45K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,826 |
1,610 |
$9K |
| 70450 |
Computed tomography, head or brain; without contrast material |
92 |
88 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
16 |
16 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,323 |
2,081 |
$1K |
| 80053 |
Comprehensive metabolic panel |
3,391 |
3,113 |
$232.36 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
838 |
779 |
$34.35 |
| 81001 |
|
1,838 |
1,736 |
$11.26 |
| 87400 |
|
1,112 |
1,063 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
417 |
396 |
$0.00 |
| 71046 |
Radiologic examination, chest; 2 views |
613 |
594 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
351 |
310 |
$0.00 |
| 81003 |
|
633 |
608 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,522 |
1,387 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
695 |
646 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
86 |
84 |
$0.00 |
| 81025 |
|
294 |
283 |
$0.00 |
| 87420 |
|
28 |
28 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
198 |
174 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
97 |
84 |
$0.00 |
| 85610 |
|
12 |
12 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
25 |
24 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
17 |
13 |
$0.00 |
| 84484 |
|
441 |
411 |
$0.00 |
| 71045 |
Radiologic examination, chest; single view |
845 |
808 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,578 |
3,287 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,657 |
1,495 |
$0.00 |
| 83690 |
|
892 |
829 |
$0.00 |
| 83735 |
|
676 |
643 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
563 |
547 |
$0.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,315 |
2,112 |
$0.00 |
| 87430 |
|
377 |
371 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
72 |
70 |
$0.00 |
| 87081 |
|
326 |
320 |
$0.00 |
| 87088 |
|
517 |
482 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
573 |
560 |
$0.00 |
| 84703 |
|
196 |
186 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
70 |
68 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
14 |
13 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,222 |
1,193 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
24 |
24 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
205 |
196 |
$0.00 |
| J3490 |
Unclassified drugs |
196 |
176 |
$0.00 |
| 96376 |
|
15 |
13 |
$0.00 |
| 82150 |
|
32 |
32 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
16 |
13 |
$0.00 |